No title
Atrial fibrillation (AF) is the most common cardiac arrhythmia worldwide, affecting an estimated 59.7 million people and imposing a growing burden on public healthcare systems. AF is characterized by a rapid and irregular heart rate. Specifically, understanding how rate-control therapies affect RR-interval variability and irregularity is essential for optimizing treatment. Accurate and reliable he
